Explore the words cloud of the INTEGROMED project. It provides you a very rough idea of what is the project "INTEGROMED" about.
The following table provides information about the project.
Coordinator |
LATVIJAS BIOMEDICINAS PETIJUMU UN STUDIJU CENTRS
Organization address contact info |
Coordinator Country | Latvia [LV] |
Total cost | 800˙000 € |
EC max contribution | 800˙000 € (100%) |
Programme |
1. H2020-EU.4.b. (Twinning of research institutions) |
Code Call | H2020-WIDESPREAD-2018-03 |
Funding Scheme | CSA |
Starting year | 2019 |
Duration (year-month-day) | from 2019-10-01 to 2022-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | LATVIJAS BIOMEDICINAS PETIJUMU UN STUDIJU CENTRS | LV (RIGA) | coordinator | 350˙000.00 |
2 | LUNDS UNIVERSITET | SE (LUND) | participant | 150˙000.00 |
3 | UNIVERSITY OF DUNDEE | UK (DUNDEE) | participant | 150˙000.00 |
4 | WEIZMANN INSTITUTE OF SCIENCE | IL (REHOVOT) | participant | 150˙000.00 |
INTEGROMED is aiming to provide LBMC with the opportunity to integrate the experience of research excellence institutions and existing resources by creating a research and innovation network with three internationally leading organizations in the translational medicine area – University of Dundee, Lund University, and Weizmann Institute of Science. The strategy of INTEGROMED is to increase excellence and develop sustainable approach targeting virtually all aspects of translational medicine including the optimal use of clinical and biobank resources, integration of different omics in systemic workflow, reaching development of bedside applications and fostering entrepreneurism. Project has a strong focus on study of metabolic disorders including type 2 diabetes, however the training, mentoring and stuff exchange activities as well as practical outcomes will be available for other fields including researchers, clinicians and other stakeholders in Latvia, promoting the implementation of the developed strategies at larger scale. The result of project will be accomplished by following three main objectives. (1) To improve and optimize the use of resources provided by large biobanks and prospective cohorts in combination with national health care system, improve knowledge in establishment of clinical studies for development of precision medicine approaches. (2) To strengthen collaboration-based training of specialists in areas of multi-omics approaches, bioinformatics, and modelling to increase excellence in implementing cutting edge multi omics technologies in such areas as genomics, methylation and expression profile, microbiome and metabolome analysis. (3) To elaborate a long-term strategy and sustainability plan involving all relevant stakeholders, ensure development and training in clinical applications and entrepreneurial skills to build an innovation ecosystem around LBMC.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Ilze Elbere, Ivars Silamikelis, Monta Ustinova, Ineta Kalnina, Linda Zaharenko, Raitis Peculis, Ilze Konrade, Diana Maria Ciuculete, Christina Zhukovsky, Dita Gudra, Ilze Radovica-Spalvina, Davids Fridmanis, Valdis Pirags, Helgi B. Schiöth, Janis Klovins Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals published pages: , ISSN: 1868-7075, DOI: 10.1186/s13148-018-0593-x |
Clinical Epigenetics 10/1 | 2019-12-16 |
2019 |
Dita Gudra, Saeed Shoaie, Davids Fridmanis, Janis Klovins, Hugo Wefer, Ivars Silamikelis, Raitis Peculis, Ineta Kalnina, Ilze Elbere, Ilze Radovica-Spalvina, Rolf Hultcrantz, Ģirts Šķenders, Marcis Leja, Lars Engstrand A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies published pages: 1723-1725, ISSN: 0017-5749, DOI: 10.1136/gutjnl-2018-316225 |
Gut 68/9 | 2019-12-16 |
2018 |
Mikhail Baryshev, Inna Inashkina, Kristine Salmina, Anda Huna, Thomas R Jackson, Jekaterina Erenpreisa DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells published pages: 362-366, ISSN: 1538-4101, DOI: 10.1080/15384101.2018.1426412 |
Cell Cycle 17/3 | 2019-12-16 |
2016 |
Linda Zaharenko, Ineta Kalnina, Kristine Geldnere, Ilze Konrade, Solveiga Grinberga, Jozef Židzik, Martin Javorský, Aivars Lejnieks, Liene Nikitina-Zake, Davids Fridmanis, Raitis Peculis, Ilze Radovica-Spalvina, Dace Hartmane, Osvalds Pugovics, Ivan TkáÄ, Lucia KlimÄáková, Valdis PÄ«rÄgs, Janis Klovins Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients published pages: 531-540, ISSN: 0804-4643, DOI: 10.1530/eje-16-0347 |
European Journal of Endocrinology 175/6 | 2019-12-16 |
2018 |
Ilze Elbere, Ineta Kalnina, Ivars Silamikelis, Ilze Konrade, Linda Zaharenko, Kristine Sekace, Ilze Radovica-Spalvina, Davids Fridmanis, Dita Gudra, Valdis Pirags, Janis Klovins Association of metformin administration with gut microbiome dysbiosis in healthy volunteers published pages: e0204317, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0204317 |
PLOS ONE 13/9 | 2019-12-16 |
2018 |
Vita Rovite, Yael Wolff-Sagi, Linda Zaharenko, Liene Nikitina-Zake, Elmars Grens, Janis Klovins Genome Database of the Latvian Population (LGDB): Design, Goals, and Primary Results published pages: 353-360, ISSN: 0917-5040, DOI: 10.2188/jea.je20170079 |
Journal of Epidemiology 28/8 | 2019-12-16 |
2019 |
Monta Ustinova, Ivars Silamikelis, Ineta Kalnina, Laura Ansone, Vita Rovite, Ilze Elbere, Ilze Radovica-Spalvina, Davids Fridmanis, Jekaterina Aladyeva, Ilze Konrade, Valdis Pirags, Janis Klovins Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals published pages: e0224835, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0224835 |
PLOS ONE 14/11 | 2019-12-16 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTEGROMED" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "INTEGROMED" are provided by the European Opendata Portal: CORDIS opendata.